InnovHeart

InnovHeart is a medical device company based in Milan, Italy, specializing in transcatheter mitral valve replacement (TMVR) systems for patients with mitral valve disease. Founded in 2015 by Giovanni Righini, the company also has a presence in the United States, particularly in Boston and Newton, Massachusetts. The flagship product, the Saturn System, is a TMVR technology platform designed for both trans-apical and trans-septal delivery methods. This innovative prosthetic valve is tailored to fit the mitral valve anatomy, featuring a sub-annular ring that promotes inverse remodeling of the mitral annulus. InnovHeart aims to provide a safe and effective solution for mitral valve incompetence, which affects around 2% of the global population, through a less invasive procedure that minimizes the need for surgical preparation. The company is currently conducting clinical trials to validate the safety and efficacy of the Saturn prosthesis. InnovHeart is committed to high-quality standards, holding ISO 13485:2016 certification for its Quality Management System. The company targets cardiologists and patients, focusing on improving outcomes in cardiovascular care with its innovative solutions.

• Employees 24
• Founded 2015
• Annual Revenue $3500000
• Total Funding $78577704